TY - JOUR
T1 - Compounding of Veterinary Drugs for Equine Practitioners
AU - Stanley, Scott D.
AU - Moffitt, Krysta
AU - Wiebe, Valerie
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.
AB - Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.
KW - Compounding
KW - Drugs
KW - Extralabel drug use
KW - Horses
UR - http://www.scopus.com/inward/record.url?scp=85015651067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85015651067&partnerID=8YFLogxK
U2 - 10.1016/j.cveq.2016.12.003
DO - 10.1016/j.cveq.2016.12.003
M3 - Review article
C2 - 28325180
AN - SCOPUS:85015651067
SN - 0749-0739
VL - 33
SP - 213
EP - 225
JO - Veterinary Clinics of North America - Equine Practice
JF - Veterinary Clinics of North America - Equine Practice
IS - 1
ER -